For more than 25 years, CooperSurgical has been a leader in manufacturing and marketing a wide range of trusted and innovative brands that have assisted clinicians in advancing the standard of health care for women worldwide. Through an aggressive growth and diversification strategy, CooperSurgical has evolved its portfolio to include key products and services for women's health, fertility and genetic testing. Our global in-vitro fertilization (IVF) segment, comprised of ORIGIO, Research Instruments, The Pipette Company, K-Systems and Wallace, and our groundbreaking offering from the pioneers of genetic testing, Recombine, Reprogenetics, and Genesis Genetics, complement our dynamic women's health care offering.
CooperSurgical, Inc. is a wholly owned subsidiary of The Cooper Companies (NYSE:COO) and is headquartered in Trumbull, CT. Through the delivery of insightful technologies and products to health care providers, we envision a world with healthier babies, individuals, and families.